The Ozempic era in Hollywood is not over, it is just evolving. Kris Jenner, appearing on the SHE MD Podcast on May 5, became the latest high-profile figure to confirm what has been circulating quietly for months: that the GLP-1 drugs like Ozempic, that became the entertainment industry’s worst-kept secret are not working for everyone, and that the more image-conscious corners of Hollywood are already finding their way to alternatives.
“I tried it,” Jenner said of Ozempic. “We tried it once when no one knew what it was, and it made me really sick.” Nauseous, unable to work, unable to function. Her doctor, OBGYN Dr. Thais Aliabadi, eventually pivoted her toward peptide injections, short chains of amino acids that can be used to induce weight loss and improve energy, followed by a targeted supplement regimen. “That was a game changer,” Jenner said. “That actually bought me an extra couple of hours at night.”
The 70-year-old momager is not alone in this. The pattern she describes, try Ozempic, experience significant side effects, quietly transition to something else, reflects a broader shift happening across an industry that adopted GLP-1 drugs with extraordinary speed and relatively little public scrutiny.
What made Ozempic’s Hollywood moment so significant was not just that celebrities were using a diabetes medication for weight loss. It was that so many of them were doing it while the broader cultural conversation was still loudly committed to body acceptance and anti-diet messaging. That tension has been building for several years. It has not been resolved. If anything, the quiet pivot toward peptides and alternative interventions suggests the industry is trying to have it both ways: the results of pharmaceutical weight management without the baggage of the specific drug everyone now associates with it.
Hollywood Ozempic Alternatives: The Cultural Contradiction Nobody Is Addressing
The medical establishment has been consistent on this point, and consistently ignored. Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital, told People directly: “The Hollywood trend is concerning. We’re not talking about stars who need to lose 10 lbs. We’re talking about people who are dying of obesity, are going to die of obesity.”
The drugs were designed for the latter. They have been widely deployed for the former. That gap between intended use and actual application is where most of the honest conversation about Ozempic in Hollywood needs to happen, and it largely has not. Jenner’s pivot to peptide injections does not resolve that contradiction. Injectable peptides carry their own medical cautions; the American Medical Association notes that the effects of some have not been studied extensively, and potential side effects range from stomach discomfort to pancreatitis.
Moving from one injectable weight management tool to another does not address the underlying question of whether the intervention is medically appropriate. What it does do is remove the specific cultural stigma that has attached to the Ozempic name. That is a meaningful distinction in an industry where optics function as currency.
What the Celebrities Actually Said
The range of public positions on GLP-1 drugs among Hollywood figures tells the full story of the contradiction. Oprah Winfrey was perhaps the most significant voice to come forward, stating in March 2024 that she “never dreamed we would be talking about medicines that are providing hope for people like me who have struggled for years.” Later that year, she acknowledged using weight loss medication publicly, knowing the pushback would be significant. “I knew that admitting to being on medication was going to be a big freaking deal. I knew I was going to get lots of pushback. And I did.”
Kate Winslet arrived at a very different conclusion. In a December 2025 Sunday Times interview, she described the current landscape as “f—— chaos” and expressed alarm at the speed with which the industry had embraced pharmaceutical weight intervention. “Do they know what they are putting in their bodies? The disregard for one’s health is terrifying.”
The space between Oprah’s relief and Winslet’s alarm is where most of the honest reckoning with this moment needs to happen. One woman found in these medications a form of medical justice after decades of struggle. Another looked at the same landscape and saw an industry dismantling whatever progress body acceptance had made. Both readings are available from the same set of facts.
What Comes After Ozempic
Kris Jenner finally confirms she tried Ozempic after speculation: ‘Made me really sick’ https://t.co/tqEVsDZLhD pic.twitter.com/9eMrpLDzwx
— New York Post (@nypost) May 7, 2026
Peptide injections are where Kris Jenner has landed, but they are not the only Ozempic alternative circulating in Hollywood’s wellness infrastructure. The broader category of weight management tools available to people with significant disposable income and access to concierge medicine has expanded considerably, and the industry’s appetite for results without public accountability has not diminished. What has changed is the specific drug attached to the conversation.
The more consequential shift may be cultural rather than pharmaceutical. The body acceptance movement that Lizzo referenced in her Marie Claire interview, “a pendulum that swung that was so body acceptance, positivity, everybody be who they want to be,” has not disappeared. It has simply been outrun, at least in the spaces where Hollywood sets its aesthetic standards.
Whether peptides become the next Ozempic in terms of cultural visibility, or whether the industry continues managing this conversation more quietly than it did the GLP-1 moment, will depend largely on how many more Kris Jenners decide to pull back the curtain. She was asked how she maintains her looks. She answered honestly. That honesty, in this particular conversation, is rarer than it should be.
Featured image: @krisjenner/Instagram
